Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|DF6002||DF-6002|DF 6002||DF6002 is a fusion protein consisting of interleukin-12 (IL-12) linked to an Fc fragment, which binds to the IL-12 receptor and may lead to activation of the immune response, inhibition of tumor cell proliferation and tumor cell killing (NCI Drug Dictionary).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT04423029||Phase Ib/II||DF6002 DF6002 + Nivolumab||A Study to Assess DF6002 (BMS-986415) Alone and in Combination With Nivolumab in Participants With Locally Advanced or Metastatic Solid Tumors||Recruiting||USA | FRA | ESP||0|